Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Lexicon Pharmaceuticals, Inc.

NASDAQ: LXRX · Life Sciences · 3 alerts · CIK 1062822

Share price
$1.75Close, Nov 16
Market cap
$779M
Shares outstanding
445.23MLatest SEC cover page
Sector
Life Sciences
Industry
Pharmaceutical PreparationsSIC 2834

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Lexicon Pharmaceuticals, Inc. filings on SEC EDGAR ↗

4:05 PM ET 10-Q
Financial Results

Lexicon Pharmaceuticals Q3 2026 Results: Net Loss of $14M, Loss Widens

Lexicon Pharmaceuticals reported a net loss of $46.8 million for the nine months ended September 30, 2026, compared to $34.8 million in the prior year period. The company strengthened its balance sheet through common and preferred stock issuances, ending the period with $183.2 million in cash and short-term investments.

Key figure
Net loss $14M
7:08 AM ET 8-K
Financial Results

Lexicon Pharmaceuticals Financial Results

Lexicon Pharmaceuticals reported Q3 2026 financial results and provided clinical updates, including the completion of enrollment for its Phase 3 SONATA-HCM study. The company also confirmed it has achieved the safety data requirements for its ZYNQUISTA NDA resubmission in type 1 diabetes.

Term
3 months

“This quarter brought Lexicon into sharper focus as a cardiometabolic company and has positioned us to approach 2027 with strong momentum and multiple near-term potential catalysts and paths to value creation.”

Mike Exton, Ph.D., Lexicon’s chief executive officer and director

“As we prepare for several important milestones across our portfolio, we remain focused on investing prudently to support execution and position the Company for long-term success.”

Scott Coiante, Lexicon’s chief financial officer

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.